Literature DB >> 19252766

Gene-gene interaction between CARD8 and interleukin-6 reduces Alzheimer's disease risk.

Ana Fontalba, Olga Gutiérrez, Javier Llorca, Ignacio Mateo, José Luis Vázquez-Higuera, José Berciano, José Luis Fernández-Luna, Onofre Combarros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19252766     DOI： 10.1007/s00415-009-5080-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk.

Authors:  Onofre Combarros; Jon Infante; Javier Llorca; Nicolás Peña; Carlos Fernández-Viadero; José Berciano
Journal:  J Neurol       Date:  2005-03-22       Impact factor: 4.849

2.  CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis.

Authors:  Marjaneh Razmara; Srinivasa M Srinivasula; Lin Wang; Jean-Luc Poyet; Brad J Geddes; Peter S DiStefano; John Bertin; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

3.  TUCAN (CARD8) genetic variants and inflammatory bowel disease.

Authors:  Dermot P B McGovern; Helen Butler; Tariq Ahmad; Marta Paolucci; David A van Heel; Kenichi Negoro; Pirro Hysi; Jiannis Ragoussis; Simon P L Travis; Lon R Cardon; Derek P Jewell
Journal:  Gastroenterology       Date:  2006-08-05       Impact factor: 22.682

4.  Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

Authors:  B Kaltschmidt; M Uherek; B Volk; P A Baeuerle; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Inflammation in neurodegenerative disease--a double-edged sword.

Authors:  Tony Wyss-Coray; Lennart Mucke
Journal:  Neuron       Date:  2002-08-01       Impact factor: 17.173

6.  Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity.

Authors:  Ana Fontalba; Victor Martinez-Taboada; Olga Gutierrez; Carlos Pipaon; Natividad Benito; Alejandro Balsa; Ricardo Blanco; Jose L Fernandez-Luna
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

7.  The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].

Authors:  Roberto Pola; Andrea Flex; Eleonora Gaetani; Antonio Dal Lago; Laura Gerardino; Paolo Pola; Roberto Bernabei
Journal:  Neuroreport       Date:  2002-09-16       Impact factor: 1.837

8.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Interleukin-6 in the aging brain.

Authors:  J P Godbout; R W Johnson
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478
  9 in total
  6 in total

Review 1.  Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.

Authors:  Limeng Dai; Dan Liu; Hong Guo; Yanyan Wang; Yun Bai
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

Review 2.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

3.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.

Authors:  Ming D Li; Qing Xu; Xiang-Yang Lou; Thomas J Payne; Tianhua Niu; Jennie Z Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

4.  IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease.

Authors:  Hui-Ping Qi; Zheng-Yi Qu; Shu-Rong Duan; Shu-Qin Wei; Shi-Rong Wen; Sheng Bi
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

5.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

6.  Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.

Authors:  Greta Pšemeneckienė; Kęstutis Petrikonis; And Daiva Rastenytė
Journal:  Medicina (Kaunas)       Date:  2019-10-15       Impact factor: 2.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.